CIK 0000886163
- Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 770160744
- Phone
- +1 858-550-7500
- Business address
- 7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,384,247
- in 9 filings, $4.7M under 10b5-1 plans
Net −$7,384,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-12 | FOEHR MATTHEW W President and COO | Exercise or conversion | +5,621 | $9.97 | $56K | 98,341 |
| 2017-05-12 | FOEHR MATTHEW W President and COO | Sale | −5,621 | $112.20 | $631K | 92,720 |
| 2017-05-12 | FOEHR MATTHEW W President and COO | Exercise or conversion · Employee Stock Option (right to buy) | −5,621 | 52,235 | ||
| 2017-05-12 | Aryeh Jason Director | Sale | −14,582 | $111.87 | $1.6M | 116,651 |
| 2017-05-11 | Aryeh Jason Director | Sale | −22,665 | $110.04 | $2.5M | 131,233 |
| 2017-03-20 | HIGGINS JOHN L Chief Executive Officer | Sale | −4,000 | $109.10 | $436K | 139,171 |
| 2017-03-08 | HIGGINS JOHN L Chief Executive Officer | Sale | −4,000 | $107.06 | $428K | 128,969 |
| 2017-03-08 | HIGGINS JOHN L Chief Executive Officer | Exercise or conversion | +15,675 | $10.05 | $158K | 144,644 |
| 2017-03-08 | HIGGINS JOHN L Chief Executive Officer | Shares withheld for taxes | −1,473 | $106.92 | $157K | 143,171 |
| 2017-03-08 | HIGGINS JOHN L Chief Executive Officer | Exercise or conversion · Incentive Stock Option (right to buy) | −15,675 | 0 | ||
| 2017-03-03 | FOEHR MATTHEW W President and COO | Exercise or conversion | +2,000 | $9.97 | $20K | 92,720 |
| 2017-03-03 | FOEHR MATTHEW W President and COO | Exercise or conversion · Employee Stock Option (right to buy) | −2,000 | 57,856 | ||
| 2017-03-02 | FOEHR MATTHEW W President and COO | Exercise or conversion | +6,879 | $9.97 | $69K | 97,599 |
| 2017-03-02 | FOEHR MATTHEW W President and COO | Sale | −6,879 | $103.39 | $711K | 90,720 |
| 2017-03-02 | FOEHR MATTHEW W President and COO | Exercise or conversion · Employee Stock Option (right to buy) | −6,879 | 59,856 | ||
| 2017-02-28 | Aryeh Jason Director | Sale | −7,000 | $107.58 | $753K | 153,898 |
| 2017-02-27 | Aryeh Jason Director | Sale | −25,000 | $106.00 | $2.6M | 160,898 |
| 2017-02-24 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award | +2,619 | 40,546 | ||
| 2017-02-24 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award | +2,259 | 42,805 | ||
| 2017-02-24 | Berkman Charles S VP, Gen. Counsel & Secretary | Grant or award · Employee Stock Option (right to buy) | +9,643 | 9,643 |
Page 58 of 86 · 1,712 trades